Addictive Behavior Control Circuit Discovered in Rat Brains
Addictive Behavior Control Circuit Discovered in Rat Brains

Addictive Behavior Control Circuit Discovered in Rat Brains

Some rats showed a decrease in addictive tendencies when researchers activated the pathway, while the behavior of others became more addictive when the pathway was inhibited.

Lisa Winter
Lisa Winter

Lisa Winter became social media editor for The Scientist in 2017. In addition to her duties on social media platforms, she also pens obituaries for the website. She graduated from Arizona State University, where she studied genetics, cell, and developmental biology.

View full profile.

Learn about our editorial policies.

Jan 3, 2020


In a recent study of more than 900 rats, Shelly Flagel and her team of neuroscientists at the University of Michigan found that a region in the thalamus of rats regulates a circuit linked to the prelimbic cortex, a brain region that governs certain urges linked to addiction. This pathway may one day become a new therapeutic target, according to a paper published last September in eLife

The team presented the rats with an inactive lever and then delivered food down a nearby chute. The rats were grouped based on how they responded to the presence of the lever. One group, dubbed “goal-trackers,” were only interested in the chute upon seeing the lever, a predictable conditioned response. The “sign-trackers,” on the other hand, enthusiastically engaged with the lever itself, even though they were not able to cause the food to come down.

The thalamus is a communication hub in the brain, directing sensory and motor inputs to relevant areas of the brain for processing and sending responses out to the body. Addiction can occur when these pathways are not functioning correctly, and there is a compulsion to engage in behaviors associated with the release of dopamine and other “feel-good” neurotransmitter rewards. 

The difference in behavior between the two groups of rats came down to the communication between the prelimbic cortex and the paraventricular nucleus of the thalamus. Through the use of chemogenetics and microdialysis, the team activated the circuit, causing the sign-trackers to lose interest in the lever, while goal-trackers were unaffected. With the pathway inhibited, goal-trackers were drawn to the lever, while sign-trackers were unaffected.

Moving forward, the researchers will search for homologous circuits in humans, with the ultimate goal of finding new therapeutic targets for treating addiction, a biologically complex mental health condition, Flagel tells Scientific American. “Once we’ve established the sign- and goal-tracker paradigm in humans, we can test whether these traits are predictive of psychopathology,” she says. “We hope this will help identify individuals who are more susceptible to certain mental illnesses or facets such as relapse.”

Lisa Winter is the social media editor for The Scientist. Email her at